Loading...
Toku-E began its journey in 1981 as a chemical trading company in Tokyo, Japan, under the name TOKUICHI, meaning "moral first" in Japanese. Over the years, it evolved from its trading roots to focus on antibiotic manufacturing through fermentation, eventually specializing in the pharmaceutical and biotech research sectors. To reflect this transformation, the company rebranded as TOKU-E, now recognized as a leading global manufacturer of innovative antimicrobials.
With a mission to simplify the work of research scientists, Toku-E provides advanced antimicrobial solutions that eliminate contamination and optimize gene selection, paving the way for discoveries in cell and plant biology, microbiology, virology, stem cell therapy, and cancer research.
Toku-E’s development pipeline continuously delivers novel antibiotic products designed to streamline workflows, enhance research outcomes, and save valuable time. The company operates ISO 9001:2015-certified facilities in the USA, Europe, and Singapore, ensuring consistent quality across its global operations. Additionally, an extensive network of distributors provides region-specific expertise and support.
By offering cutting-edge antimicrobial products, Toku-E empowers researchers worldwide to achieve breakthroughs with greater efficiency and precision.
Cell culture is a cornerstone of modern biological research, enabling scientists to study cellular processes, develop new therapies, and explore genetic modifications. However, maintaining uncontaminated and reproducible cultures remains a persistent challenge. Contaminants like bacteria, fungi, and Mycoplasma can compromise experimental integrity, leading to unreliable results and wasted resources.
Companies like Toku-E provide specialized solutions to address these challenges. Their portfolio includes selection antibiotics, antimycotics, and Mycoplasma detection and elimination products, which are crucial for preventing contamination and optimizing transfection protocols. These products cater to mammalian, insect, and stem cell cultures, supporting a broad spectrum of research applications.
By integrating high-quality antimicrobial solutions into cell culture workflows, researchers can ensure better reproducibility, maintain cell viability, and enhance experimental outcomes. Access to reliable reagents not only streamlines laboratory processes but also accelerates scientific discoveries in fields such as biotechnology, regenerative medicine, and pharmaceutical development.
